Literature DB >> 20335495

Identification of key amino acid residues required for horseshoe bat angiotensin-I converting enzyme 2 to function as a receptor for severe acute respiratory syndrome coronavirus.

Meng Yu1, Mary Tachedjian, Gary Crameri, Zhengli Shi, Lin-Fa Wang.   

Abstract

Angiotensin-I converting enzyme 2 (ACE2) is the receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV). A previous study indicated that ACE2 from a horseshoe bat, the host of a highly related SARS-like coronavirus, could not function as a receptor for SARS-CoV. Here, we demonstrate that a 3 aa change from SHE (aa 40-42) to FYQ was sufficient to convert the bat ACE2 into a fully functional receptor for SARS-CoV. We further demonstrate that an ACE2 molecule from a fruit bat, which contains the FYQ motif, was able to support SARS-CoV infection, indicating a potentially much wider host range for SARS-CoV-related viruses among different bat populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335495     DOI: 10.1099/vir.0.020172-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.

Authors:  Marissa LoPresti; David B Beck; Priya Duggal; Derek A T Cummings; Benjamin D Solomon
Journal:  medRxiv       Date:  2020-06-03

Review 2.  SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission.

Authors:  Meagan Bolles; Eric Donaldson; Ralph Baric
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

Review 3.  Emerging zoonotic viruses: new lessons on receptor and entry mechanisms.

Authors:  Denis Gerlier
Journal:  Curr Opin Virol       Date:  2011-06-12       Impact factor: 7.090

Review 4.  Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.

Authors:  Richard J Head; Eugenie R Lumbers; Bevyn Jarrott; Felix Tretter; Gary Smith; Kirsty G Pringle; Saiful Islam; Jennifer H Martin
Journal:  Pharmacol Res Perspect       Date:  2022-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.